Navigation Links
Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations

NEW YORK, Dec. 8 /PRNewswire/ -- Duane Reade Holdings, Inc. today announced the appointment of Mr. Frank Scorpiniti, 38, as Senior Vice President of Pharmacy Operations effective December 1, 2008. Mr. Scorpiniti reports directly to John Lederer, Chairman and Chief Executive Officer. His appointment adds value and expertise to Duane Reade's capable management team which has recently benefited from the appointments of several other senior executives.

Mr. John Lederer, Chairman and Chief Executive Officer, commented, "We are very pleased to have Frank Scorpiniti join our strong management team as Senior Vice President of Pharmacy Operations. We are confident that Frank's many years of experience in the pharmacy industry and his strong track record in raising customer service standards will help us to significantly improve our pharmacy business and increase the accessibility and availability of our pharmacy offerings."

Mr. Scorpiniti, a 13-year veteran of the pharmacy industry, comes to Duane Reade from Longs Drug Store Corporation, a West Coast regional pharmacy chain store that recently became a wholly-owned subsidiary of CVS Caremark Corporation. Mr. Scorpiniti held positions of increasing responsibility throughout his career at Longs and most recently served as Vice President of Pharmacy Operations, overseeing all aspects of Longs' pharmacy business.

Mr. Scorpiniti received his doctorate of pharmacy from University of the Pacific in Stockton, California.

About Duane Reade

Founded in 1960, Duane Reade is the largest drug store chain in the metropolitan New York City area, offering a wide variety of prescription and over-the-counter drugs, health and beauty care items, cosmetics, greeting cards, photo supplies and photofinishing. As of September 27, 2008, the Company operated 245 stores.

Except for historical information contained herein, the statements in this release and the accompanying discussion on the earnings conference call are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, this document may contain statements, estimates or projections that constitute "forward-looking" statements as defined under U.S. federal securities laws. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted or expected results. Those risks include, among other things, the competitive environment in the drug store industry in general and in the New York metropolitan area, the ability to open and operate new stores, the continued efforts by payers and government agencies to reduce prescription reimbursement rates and prescription drug benefits,

the strength of the economy in general, the economic conditions in the New York greater metropolitan area, changes in federal and state laws and regulations, including the potential impact of changes in regulations surrounding the importation of pharmaceuticals from foreign countries and changes in laws governing minimum wage requirements, changes in the Company's operating strategy, capital expenditure plans or development plans, the Company's ability to attract, hire and retain qualified pharmacy and other personnel, the Company's significant indebtedness, labor disturbances, the continued impact of, or new occurrences of, terrorist attacks in the New York greater metropolitan area and any actions that may be taken in response, demographic changes, the Company's ability to limit fraud and shrink, the

results of the Company's legal proceedings and recalls of pharmaceutical products due to health concerns or other reasons. Those and other risks are more fully described in Duane Reade's reports filed with the SEC from time to time, including its annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

     Contact:   Duane Reade Holdings, Inc.
                John Henry
                Chief Financial Officer
                (212) 273-5746

    Investors:  Cara O'Brien/Caren Villarreal
    Press:      Diane Zappas
                (212) 850-5600

SOURCE Duane Reade Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Duane Reade Holdings, Inc. Reports Third Quarter Results
2. Duane Reade Goes Pink to Support 2008 Komen New York City Race for the Cure(R)
3. Duane Reade Announces Proud Sponsorship of AIDS Walk New York
4. Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer
5. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
6. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
7. Gerstman Family Spotlighted on Readers Digest Website
8. Health Book Summaries Subscriber Base Grows to 60,000 Readers as Health Consumers Applaud Free Format
9. Misys Wins Best Trade Processing Product Accolade in European Banking Technology Readers Choice Awards
10. Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Readers Digest for Exemplifying the Fight Against Breast Cancer
11. Superfast Lightweight Free PDF Reader is Launched by Drumlin Security
Post Your Comments:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ProSidebar: ... in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily add ... ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 2015 --> --> ... to find optimal contrast weighting of MRI for patients ... signed a research agreement with SyntheticMR in order to use ... it is possible to generate multiple contrast images from a ... has left, thus making it possible to both fine tune ...
Breaking Medicine Technology: